A recent publication in JACC: Advances shows a previously unrecognized link between cardiac disease and cancer. The research focused on cardiac biomarkers, which are biological molecules that can ...

Please provide your email address to receive an email when new articles are posted on . Elevated levels of cardiac biomarkers were indicative of future cancer risk. The association between biomarkers ...

Keep reading to learn how biomarker-guided cardioprotection may improve heart outcomes during anthracycline cancer treatment.

Acute ischemic stroke, resulting from the occlusion of cerebral arteries, remains a leading cause of morbidity and mortality worldwide. In recent years, there has been growing recognition that cardiac ...

Heart failure, in the simplest of terms, indicates that a problem with the ventricles is preventing the heart from filling and/or pumping correctly. It is the result of a complex mechanical and ...

Patients hospitalized for influenza are just as likely as those admitted for COVID-19 to have signs of myocardial involvement, according to a study out Ontario, Canada. Though patients with COVID-19 ...

Nearly 1 in 5 US adults with type 2 diabetes but without symptoms of cardiovascular disease (CVD) have a clinically meaningful elevation of a marker of cardiac damage — namely, high sensitivity ...

Clinical Outcomes Research Showing a Correlation between NT-proBNP and Health-related Quality of Life DUBLIN, Ireland, Aug. 15, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a ...

SHENZHEN, China, Oct. 23, 2023 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac ...

A simple blood test that can very accurately predict the chance of survival with good recovery will be of great significance for patients in intensive care after a cardiac arrest. This assertion comes ...